{"name":"Noah Pharmaceuticals, Inc.","slug":"noah-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MAR","genericName":"MAR","slug":"mar","indication":"Major depressive disorder","status":"marketed"}]}],"pipeline":[{"name":"MAR","genericName":"MAR","slug":"mar","phase":"marketed","mechanism":"MAR is a medication that works by inhibiting the reuptake of norepinephrine, serotonin, and dopamine.","indications":["Major depressive disorder","Attention deficit hyperactivity disorder (ADHD)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZzhwR1pzamVxaTVIR3VZeC1lZC01dWUzZ2hqb1Fqc01DcFFwOUlTVmR1dHlpMmVwbVIzT0hja01UR1RWX0dIYXM3NjZtXzI4VG56dEF1N05Hc01mOTQtUzA4a1FmdXE1cmhNVFYyMzZVbFVkejRQb0QxSXVVeG1yeDZVTmlIZjRYQk9YR1dEaHU1MjJYMlB6NFhxeG5zbEtkWWZLbWxOR0VvVzJWcV9wN1JnWExTQ0hvdEx5RHFkVkxqUm8?oc=5","date":"2026-03-16","type":"pipeline","source":"Fierce Pharma","summary":"J&J files trade secret lawsuit against former oncology employee linked to Summit Therapeutics - Fierce Pharma","headline":"J&J files trade secret lawsuit against former oncology employee linked to Summit Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1CdDRMQnNrUUtVRFVTNUlyc3UtUzBheVFhMmJIOVNJN3Rlem9qcEwwT2VDU0g0Z3k4dGxjTVBLejB5TW93bHYySkx3bnZRS2w0OEtLcWNOLUNua1dQd19OMEs0X1h4bXpCWm9zTWZ6cnVMRndLMW53RA?oc=5","date":"2026-02-06","type":"pipeline","source":"neurologytoday.aan.com","summary":"Pharmaceutical Company Discontinues Acute Migraine Treatment Lasmiditan - neurologytoday.aan.com","headline":"Pharmaceutical Company Discontinues Acute Migraine Treatment Lasmiditan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxORkhya3VZZFdTM0c5cDFUWVNQVjRaUnRwYXNNcjJHNTN6WnEzMVRKOWV2WGtXcUttYVJTa3diWDlwRUxJc2ZSQVBwRWwwRG5TYWg5cUtrbnEwTFhpZm04bV9peUxVaUNraU1hb3lLNmN2cHZaLW5vbm5odXQ0ZjhKTW03NS01RU5h?oc=5","date":"2025-11-26","type":"pipeline","source":"조선일보","summary":"AI Cuts South Korea's Drug Development Time from 10 to 2-3 Years - 조선일보","headline":"AI Cuts South Korea's Drug Development Time from 10 to 2-3 Years - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOZUIyRzVma2dkNjBSLThQeWl4ekRmbmlDVi02RGtnN3hCa2Jvc051dzNnOFRGZ0lDMnZzeEpkVUVhQm9VYTZabkxWVTQyQUk2bEhrRy1YS1l0NVBpZWtrLU9kRE9CY05BMWR1djFsRVFxQVBINjY1QlkzV09GSVJYWjlBNHNQaFd1?oc=5","date":"2025-10-14","type":"regulatory","source":"CGTLive®","summary":"BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again - CGTLive®","headline":"BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again - CGTLive®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNYk5mRjFKaF81WlFVVDZzSmVybUVOUDB5by1fQ1ktaElPT01OZGt1WVpBNGpIaThqUXJSVlFpMTNEWXJWN1pYd0RlMGNPTEN1aldXNUZZczlGb3BYbEZpTTRnYmdSN0FxalpwaXN0VXUxby1OLUYtQ1Y5ZWE1YmxISTVsTVBYdnY3eG5fMUx2bkVfeFp5OFE?oc=5","date":"2025-10-06","type":"pipeline","source":"CGTLive®","summary":"Rocket Pharmaceuticals Pulls BLA for Fanconi Anemia Gene Therapy RP-L102 - CGTLive®","headline":"Rocket Pharmaceuticals Pulls BLA for Fanconi Anemia Gene Therapy RP-L102 - CGTLive®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1JRHZFd215cVZLYjBVODF3MFN6SWltU1BiSDNBVGJLVmx2OUFsZEpLUWo4U0JwSk1pTEJGUmhVQlI0MTlXb3NUYUxOc2tjU1ZBWWVzaVZWV180Mk1FeFk2SnRESlo2dTlBMFRhc3NtUXN1TTU2bU5J?oc=5","date":"2025-08-29","type":"deal","source":"The Microdose | Substack","summary":"Pharmaceutical company AbbVie to buy Gilgamesh depression drug program for up to $1.2 billion; Kentucky committee discusses ibogaine; and Colorado listening session on Natural Medicine Program - The M","headline":"Pharmaceutical company AbbVie to buy Gilgamesh depression drug program for up to $1.2 billion; Kentucky committee discus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9IdzBSVFNMOHh4dml4VGtsWjZMWDNna3VERkFRTkVZUDMyS1BSSVhHUW5JU0gwX01ZVkFIN3hEUXhncGlkRzdrVFZxTmN5RUt0MlQ4cWZMV0dWODRUQUVRUUh1dnJUREZjVlpFVFNn0gFyQVVfeXFMTnlJaHo3Tm85cy1DVVBJbXJCeXY5VDNEak5Pc2FwTElzQXpWSThVWTVYMk9JTlVTTUpfTERGUV9OUmRzVWtvSDE0bnc3OVVpeGdvVTM2b1AyT2dGZGRCT1d6bHJaMXJxbEtKbGtZR0l4WEJn?oc=5","date":"2025-08-01","type":"pipeline","source":"koreabiomed.com","summary":"Dr.Noah Biotech, Thermo Fisher explore AI collabo for rare disease drug development - koreabiomed.com","headline":"Dr.Noah Biotech, Thermo Fisher explore AI collabo for rare disease drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPM01fTEF2X3BuZ2g4N0h0ZnpfMkF5aUF6a3pfZENkckVGYXlHdVdFaDdSVHlsRkZsdEVxS2FxbWd1by02U1NCVnVTZDlhRWI0MjRIbEx4OEZPNWVmcF9CRjBvZElnbEsyWGtxd0h6cVlsNDRjSnZ1Z2I4U0QyRE1jckVGZjdDWTdWSEVsTlBoM0l4RHFZTVpyU0NzbkhEVHhrUTV5NG1rYS04UkxTVklFRlVib21kcFg1S2FRZVRwWm9JWm9fZDBEOTdTNVp5Mk1DcERTZE4tYw?oc=5","date":"2025-05-16","type":"trial","source":"CGTLive®","summary":"Rocket’s PKP2-Arrhythmogenic Cardiomyopathy Gene Therapy RP-A601 Improves or Stabilizes Heart Function in Phase 1 Trial - CGTLive®","headline":"Rocket’s PKP2-Arrhythmogenic Cardiomyopathy Gene Therapy RP-A601 Improves or Stabilizes Heart Function in Phase 1 Trial ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9fXzZzX0xsd1RoeTNlWWlqeXhGMndYZUF6TTljOXhqWjBudjlydXI4d2Y5S1hfUmVielZrOFF2MThPSUFtM19aQUxmR2d0dFo0YUhhR2RIX3dadFdoQVROaHhaX0N2ckFTcUZ6UWxweDFILWxPRmc?oc=5","date":"2024-09-03","type":"regulatory","source":"Clinical Trials Arena","summary":"DR.NOAH BIOTECH’s Phase I trial of ALS treatment receives approval from FDA - Clinical Trials Arena","headline":"DR.NOAH BIOTECH’s Phase I trial of ALS treatment receives approval from FDA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOcTVhdGEwVW9ualQzaWNmcWFJcjV4SEFGWVlpajNYc3lBbTJEdnBveFNKd01aaXNUT0lOd3IxYVRBVE1pZ09wc0FTbFpKLXdaUEx1M05fcXIycFg3Wk1qY3BuR0JNN3VPX3F2YURlamVrVDZmNlFoSUlHOU1YbnJfcGtRRnd6ZUw4R21jZg?oc=5","date":"2024-02-01","type":"pipeline","source":"The New York Times","summary":"U.S. Makes Initial Offers in Medicare Drug Price Negotiations (Published 2024) - The New York Times","headline":"U.S. Makes Initial Offers in Medicare Drug Price Negotiations (Published 2024)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5NMUpyRFE1UTh6RTFFSHRoWEp0eUFsaUJVWGFrMGhobHJrVmhLMEYyb09oa0ppSDZ0Qm9PQlZfUmdKNkNJQV9jOUZ6dG1mZ2Y3MnQ1ZXZfcHdnZ2Ffa01sM29pel9xVFBxcjVvTGlOVW9IZ0pqS0pzbHhB?oc=5","date":"2023-05-18","type":"earnings","source":"Investopedia","summary":"Top Pharmaceutical Stocks for Q2 2023 - Investopedia","headline":"Top Pharmaceutical Stocks for Q2 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOQVJTSGpXdzdPZm02Qm1fbWg3RFY2UnM0ODkzQlNqc0Y4UGZfVkpZV3UzVmlCNnVUZnA2a2ZscGlvSmdGLTY0S0NZUDVRUEJkTVJyazNhLU5zdDlCM1I0dFJrcl9zdkFXdTg3ckxqMWRpVE90U1pQS0QzNGs4YTdTZ1R3aW5wdE44dVZqQ04xUzJNRkl6dFNDcm1GeExCcEJTVmdsU1A0NA?oc=5","date":"2019-03-21","type":"pipeline","source":"findlaw.com","summary":"Family Sues Maker of 'Stay Awake' Caffeine Pills After Son Dies - findlaw.com","headline":"Family Sues Maker of 'Stay Awake' Caffeine Pills After Son Dies","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}